Tag: Patient Capital

Luma Group Closes $410 Million Life-Sciences Venture Fund: Why Its 15-Year Strategy Could Change Biotech Investing
Luma Group Closes $410 Million Life-Sciences Venture Fund: Why Its 15-Year Strategy Could Change Biotech Investing

Luma Group Closes $410 Million Life-Sciences Venture Fund: Why Its 15-Year Strategy Could Change Biotech Investing

Luma Group Closes $410 Million Life-Sciences Venture Fund: Why Its 15-Year Strategy Could Change Biotech Investing. VentureStreets.com | Venture Capital, Startup & Investment IntelligencePublished: September 2026 Luma..